## **Core Concept**
Pseudomonas aeruginosa is a Gram-negative bacterium known for its intrinsic resistance to many antimicrobial agents. This resistance is largely due to its unique outer membrane structure, which includes a low permeability outer membrane and the presence of efflux pumps.

## **Why the Correct Answer is Right**
The correct answer, . Amikacin is an aminoglycoside antibiotic that is effective against Pseudomonas aeruginosa. Aminoglycosides, including amikacin, work by binding to the bacterial 30S ribosomal subunit, inhibiting protein synthesis. Pseudomonas aeruginosa, however, has limited susceptibility to some aminoglycosides due to its efflux pumps and modifying enzymes, but amikacin is one of the more effective ones.

## **Why Each Wrong Option is Incorrect**
* **Option A:** . This option might seem plausible because some cephalosporins have activity against Pseudomonas. However, without specifying which one, it's hard to judge, but generally, cephalosporins like ceftazidime are effective.
* **Option B:** . This is incorrect because ciprofloxacin, a fluoroquinolone, is actually effective against Pseudomonas aeruginosa. It works by inhibiting bacterial DNA gyrase and topoisomerase IV.
* **Option D:** . This option is incorrect because piperacillin-tazobactam is a combination of a beta-lactam antibiotic (piperacillin) and a beta-lactamase inhibitor (tazobactam) that does have activity against Pseudomonas aeruginosa.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Pseudomonas aeruginosa is notoriously resistant to many antibiotics, which makes treatment challenging. For serious infections, options like amikacin (an aminoglycoside), ceftazidime (a cephalosporin), and ciprofloxacin (a fluoroquinolone) are often considered.

## **Correct Answer:** . Amikacin